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Phosphorylation of the somatomedin-C receptor  was 
investigated  both  in  intact IM-9  cells and  in  IM-9 cells 
that had been solubilized with Triton X-100. Intact 
IM-9  cells were incubated  with  [32P]H3P04  for 1 h and 
for  an  additional 5 min in  the absence or presence of 
insulin or somatomedin-C. The cells were  then solubi- 
lized and subjected  to wheat  germ  agglutinin  Sepha- 
rose  chromatography.  The  extent of phosphorylation 
of insulin  and somatomedin-C receptors  was assessed 
by immunoprecipitating the wheat germ agglutinin 
Sepharose  eluates  with monoclonal  antibodies  specific 
for  each  receptor  and  analyzing  the  immunoprecipi- 
tates by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. The @-subunits of both  receptors  were 
phosphorylated in the absence of hormone, and the 
extent of phosphorylation of each receptor was en- 
hanced  by  both  hormones.  However,  each  hormone  was 
more  potent  than  the  other  in  enhancing  phosphoryla- 
tion of its  own  receptor. 
The &subunit of the somatomedin-C receptor was 
also  phosphorylated  when  solubilized  IM-9  cells  that 
had  been  purified  on  wheat  germ  agglutinin  Sepharose 
were  incubated  with [-p3’P]ATP. In  this soluble prep- 
aration,  phosphorylation  occurred  on  tyrosyl  residues 
and  was  enhanced by concentrations of somatomedin- 
C in  the  range of 2.5 to 250 ng/ml,  which is  consistent 
with  its  receptor  affinity.  Tyrosyl  phosphorylation of 
the somatomedin-C receptor  also  occurred  when  highly 
purified  receptor,  prepared by wheat  germ  agglutinin 
Sepharose affinity chromatography followed by im- 
munoprecipitation, was incubated with [-p3’P]ATP. 
This  indicates  that  the  responsible  tyrosyl  kinase  ac- 
tivity  is  intrinsic  to  the  receptor  or  tightly associated 
with  it. 
Several viral oncogene products and their cellular homo- 
logues are  tyrosine  specific  protein  kinases  which  also  serve 
as substrates for tyrosine  phosphorylation (for example,  see 
Refs. 1-5). In cells  transformed  by  the  Rous  sarcoma  virus, 
transformation  results  from  the  action of t h e  oncogene  prod- 
uct  and  is  correlated  with  its  protein  kinase  activity (6, 7).  It 
is, therefore, interesting that receptors for several growth 
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factors  including  epidermal  growth factor (8-131, insulin (14- 
22), and  platelet-derived  growth  factor  (23,241  contain  tyrosyl 
residues  which  are  phosphorylated,  and  that  phosphorylation 
of these residues is enhanced by binding of the respective 
growth factor. In the case of epidermal growth factor and 
insulin, the evidence indicates that the receptor is itself a 
tyrosine-specific  protein  kinase,  which  is  capable  not  only of 
autophosphorylation  but  also of phosphorylating  exogenous 
proteins (10, 11, 18-21). In  the  present  studies, we investigate 
phosphorylation of the  somatomedin-C  receptor. 
MATERIALS  AND  METHODS 
Somatomedin-C was purified from Cohn Fraction IV ( 2 5 ) .  nIR-1 
is a monoclonal antibody to  the insulin receptor. aIR-2 and nIR-3 
are monoclonal antibodies to the somatomedin-C receptor. The pro- 
duction and properties of these antibodies have been described (26- 
28). IM-9 (human lymphoblastoid) cells were grown in RPMI 1640 
containing 10% bovine serum (Sterile  Systems). 
Immunopreczpitation of Solubilized Receptor-Immunoprecipita- 
tions were carried out with nIR-l (final concentration of 19 pg/ml), 
aIR-2 (final dilution of ascites fluid 1:420), or aIR-3 (final  concentra- 
tion 11 pg/ml). Normal mouse serum was included in all tubes at a 
final dilution of 1:400. Control tubes contained only normal mouse 
serum without monoclonal antibodies. Solubilized receptor was in- 
cubated with the indicated antibody in 50 mM Tris.HC1, pH 7.7, 
containing 0.2% Triton X-100 and the protease inhibitors bacitracin 
(1 mg/ml) and phenylmethylsulfonyl fluoride (20 pg/ml). In studies 
in which phosphorylated receptor was immunoprecipitated, the fol- 
lowing were added to inhibit phosphatases: 5 mM EDTA, 10 mM 
sodium pyrophosphate, 10 rnM NaF, and 0.1 mM sodium vanadate. 
After 6 h, anti-mouse immunoglobulin (Cappel) was added at a final 
dilution of 1:18 and  the incubation was continued for an additional 
18 h. Four ml  of Tris buffer containing 0.2% Triton X-100 was added, 
the tubes were centrifuged at 3,000 X g and the immunoprecipitate 
washed with an additional 4 ml of Tris buffer. 
SDS‘-Polyacylamide Gel Electrophoresis and Phosphoamino  Acid 
Determination-The immunoprecipitates were  washed with an addi- 
tional 4 ml  of  H,O, lyophilized, and subjected to SDS-polyacrylamide 
g l electrophoresis with the Laemmli buffer system. After staining, 
the gels were either dried and subjected to autoradiography and 
densitometry, or the labeled bands were  excised, electrophoretically 
eluted, and after hydrolysis in 6 N HCl, two-dimensional phosphoa- 
mino acid analysis was performed by electrophoresis (glacial acetic 
acid, 88% formic acid, H20, 78:25:897, pH 1.9) and ascending chro- 
matography (isobutyric acid, 0.5 M NH,OH, 5:3) (13). 
RESULTS 
Receptor  Phosphorylation in Intact IM-9 Cells-Intact IM- 
9 cells  were  incubated  with [:’2P]H:3P04 for 1 h to  label  their 
endogenous pool of ATP. The cells were then divided into 
three  groups,  which  were  incubated for an additional 5 min 
in  the  absence of added hormone (Fig. lA, lanes I - 4 ) ,  with 
0.5 pg/ml of insulin  (Fig.  lA,  lanes 5-81, or with 0.5 pg/ml of 
somatomedin-C  (Fig.  lA,  lanes 9-12). T h e  cells  were  washed 
rapidly  and  solubilized  with a mixture  designed  to  inhibit  both 
phosphatases and kinases, and a glycoprotein fraction was 
isolated by wheat germ agglutinin affinity chromatography 
(see Fig. 1 legend). The labeled  glycoproteins  were  then  im- 
munoprecipitated. A labeled  band  with a molecular  weight of 
approximately 90,000, which  corresponds  to the P-subunit of 
the  insulin  receptor,  was  immunoprecipitated  by (uIR-1, the 
antibody  to  the  insulin  receptor  (Fig.  lA,  lanes 2, 6, and IO). 
Although  this  band  is  labeled  even  in the absence of hormone, 
‘The abbreviations used are: SDS, sodium  dodecyl sulfate; 
HEPES, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic a id. 
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FIG. 1. Phosphorylation of insulin  and  somatomedin-C  receptor  in  intact IM-9 cells. A, 6 X 10" IM-9 
cells  were  washed  twice  with phosphate-free  RPMl 1640 and resuspended in 17 ml of phosphate-free  RPMl 1640 
containing 0.1% bovine alhumin, 18 mM HEPES buffer, pH 7.4, and 4 mCi of [:"P]H:,PO,. After  a 1-h  incuhation 
at 37 "C, 5-ml aliquots were incubated for an  additional 5 min at 3'7 "C with no  additions (lanes 1-4) .  0.5 pg/ml of 
insulin (lancs 5-0) ,  or 0.5 pg/ml of somatomedin-C (lanes 9-12).  The cells were then washed twice with 45 ml of 
phosphate-buffered  saline  containing 10 mM sodium pyrophosphate, 4 mM EDTA, 10 mM NaF,  and 0.1 mM sodium 
vanadate,  and solubilized in 50 mM Tris.HCI,  pH '7.7, containing 1 5  Triton X-100, 1 mg/ml of bacitracin, 200 pg/ 
ml of phenylmethylsulfonyl fluoride, 10 mM sodium pyrophosphate, 4 mM EDTA, 10 mM sodium  fluoride, and 0.1 
mM sodium vanadate.  The soluhilized  cells were centrifuged at 100,000 X g for 1 h and  the  supernatants applied 
to a 0.5-ml wheat germ agglutinin-Sepharose  column. The columns were washed and  eluted with 1.5 ml of 0.5 M 
N-acetylglucosamine in 50 mM Tris.HC1,  pH 7.7, containing 0.1% Triton X-100 and 1 mg/ml of bacitracin. The 
eluate was then  immunoprecipitated with normal mouse serum (lanes 1 ,  5 ,  and 9), uIR-1 (lanes 2.6, and I O ) ,  trlR- 
2 (lanes 3 ,  7, and 1 1 ) ,  or trIR-3 (lanes 4,  8, and 12) as described under  "Materials  and Methods." The 
immunoprecipitates were then subjected to  SDS-polyacrylamide gel electrophoresis  on a 6.5% gel. Shown is an 
autoradiogram of the dried gel. Standard  proteins  are "C-acetylated albumin and phosphorylase. R, IM-9 cells 
were  labeled  with  [:"P]HIPO,, as described  above, and  incuhated for 5 min at  37 "C with  no additions (lanes I - 3 ) .  
0.5 pg/ml of insulin (lanes 4-6) ,  or 20 pg/ml of insulin (lanes 7-9). The cells were then washed,  solubilized, and 
purified on a  wheat  germ agglutinin-Sepharose column as described in A. The wheat germ agglutinin-Sepharose 
eluates were immunoprecipitated with normal mouse serum (lanes I ,  4 ,  and 7 ) .  c r I R - 1  (lanes 2, .5, and R ) ,  or crIR-X 
(lanes 3, 6, and 9), as described under "Materials and Methods," and subjected to SDS-polyacrylamide gel 
electrophoresis. 
the  extent of labeling is increased approximately 4-fold by 0.5 
pg/ml of insulin  and  slightly less than 2-fold by 0.5 pg/ml of 
somatomedin-C.  (Although  other  bands  appear slightly darker 
in the lanes 2, 6, and 10 in  which nIR-1  immunoprecipitates 
were run, we doubt  that  these  bands  correspond  to compo- 
nents of the  insulin  receptor  since  they were also  precipitated 
in significant  amounts by normal mouse serum.  The  extent 
of phosphorylation of these  bands was not  enhanced by in- 
sulin or  somatomedin-C.) d R - 2  and  nIR-3,  antibodies  to  the 
somatomedin-C receptor, specifically immunoprecipitated a 
labeled hand (Fig. lA, lanes 3 ,  4, 7, 8, 1 1 ,  and 12) which was 
somewhat  broader  and  had a somewhat slower  mobility (ap- 
parent M, = 92,000-98,000) than  the  @-subunit of the  insulin 
receptor and in some cases appeared as a doublet. This is 
characteristic of the  @-subunit of the  somatomedin-C  receptor 
in IM-9 cells (27, 28).  Labeling of this  protein was enhanced 
approximately 2-fold by 0.5 pg/ml of somatomedin-C, but 
only little, if at  all, by 0.5 pg/ml of insulin. In  similar  studies 
(Fig. l R ) ,  higher concentrations of insulin  (20  pglml), how- 
ever, are  quite effective a t  stimulating  phosphorylation of this 
protein.  (With  these high concentrations of insulin,  there  was 
also enhanced labeling of a  very  high  molecular  weight band 
which is  seen at  the very top of the  separating gel (lanes 7- 
9). The significance of this  band  is  not clear; however, it is 
clear that immunoprecipitation of this band is not specific 
since it is equally dark  with  normal mouse serum  or  either 
anti-receptor  antibody.) 
Phosphorylation of Solubilized Receptor-IM-9 cells were 
solubilized with Triton X-100 and  somatomedin-C receptors 
partially purified on a wheat germ agglutinin  Sepharose col- 
umn.  The  eluted  receptor was incubated with somatomedin- 
C and  then with [y"'P]ATP (Fig. 2). The  &subunit of the 
somatomedin-C  receptor was phosphorylated in the  absence 
of somatomedin-C,  hut  phosphorylation was enhanced by as 
little as 2.5 ng/ml of somatomedin-C  and maximal enhance- 
ment occurred  with 250 ng/ml. Phosphoamino acid analysis 
indicated  that  phosphorylation occurred on tyrosyl residues 
both in the  basal  state  and  after  somatomedin-C  stimulation 
(Fig. 3). 
Solubilized somatomedin-C  receptor was partially purified 
on a wheat germ agglutinin  Sepharose column and then 
immunoprecipitated with trIR-3. The washed immunoprecip- 
itate was resuspended and  incubated with [-y-:'"P]ATP. This 
also resulted in tyrosyl phosphorylation of the &subunit; 
however, somatomedin-C  stimulation was lost. (Data  on file 
with  the  Journal of Biochemistry.)2 This may indicate  that 
Additional Figs. 4A and 4R are available as dRC  Document 
Number C89-131B. in the form of 1 microfiche(s) or 2 pages. Orders 
for supplementary material should specify the title, author(s) and 
reference to this paper and the JRC Document number, the form 
desired (microfiche or hard  copy)  and  the  number of copies  desired. 
Orders  should be addressed to  The  Journal of Biological Chemistry, 
9650 Rockville Pike, Hethesda, Maryland 20014 and must be accom- 
panied by remittance  to  the  order of the  Journal in the  amount of 
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FIG. 2. Effect of somatomedin-<: on  the  phosphorylation of 
solubilized receptor. IM-9 cells were washed three times with 
phosphate-buffered  saline  and soluhilized  with  5 ml  of 50 mM Tris. 
HCI, pH 7.7, containing 1% Triton X-100,  1  mg/ml of bacitracin,  and 
20 pg/ml of phenylmethylsulfonyl fluoride. The solubilized  cells  were 
centrifuged at 100,000 X g for 1 h and  the  supernatant applied to a 
1-ml wheat germ agglutinin-Sepharose  affinity  column. The column 
was  washed and  then  eluted with 3 ml of 0.5 M N-acetylglucosamine 
in 50 mM Tris. HCI, pH 7.7, containing 0.1% Triton X-100 and 1 mg/ 
ml  of bacitracin.  50 pl of the  wheat germ agglutinin-Sepharose  eluate 
was incuhated for 1 h at  22 'C  with the following concentrations of 
somatomedin-C: 2,500 ng/ml (lanes I and 2); 250 ng/ml (lane 3 ) ;  25 
ng/ml (lane 4 ) ;  2.5 ng/ml (lane 5 ) ;  and no somatomedin-C (lane 6). 
Reaction mixture was then added to give a final volume of 100 pl 
containing 20 mM MgCI,, 5 mM MnCI2, and 5 pM [y-"'PIATP (20 
pCi/nmol). After  10  min a t  room temperature, the reaction  was 
stopped by adding 100 pl of Tris. HCI containing 0.2% Triton X-100, 
20 mM EDTA, 20 mM NaF, 0.4 mM sodium vanadate, 20 mM sodium 
pyrophosphate, 20 mM ATP, 2  mg/ml of bacitracin  and 40 pg/ml of 
phenylmethylsulfonyl  fluoride. The  quenched reaction mixtures were 
then  immunoprecipitated with normal mouse serum (lone I )  or crIR- 
3 (lunes 2-6) and suhjected to SDS-polyacrylamide gel electrophore- 
sis.  Shown is an  autoradiogram of a dried 6.55 gel. 
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FIG. 3 .  Phosphoaminoacid analysis of the soluble somato- 
medin-<: receptor. IM-9 cells were solubilized and  the  somatome- 
din-C receptor partially purified on a wheat germ agglutinin-Sepha- 
rose column.  The  partially purified receptor was incuhated  without 
(8) or with  0.5  pg/ml of somatomedin-C ( A  and C) for 1 h,  and  then 
with [-y-T']ATP as described in the legend to Fig. 2. The samples 
were immunoprecipitated with normal mouse serum ( A )  or trlR-3 ( H  
and (') and suhjected to SDS-polyacrylamide gel electrophoresis.  The 
region of the gel corresponding  to  the  &subunit of the  somatomedin- 
C receptor were excised. electrophoretically eluted, and phosphoa- 
minoacids determined as described under  "Materials  and Methods." 
Liquid scintillation counting of the phosphotyrosine from the  thin 
layer chromatography plate revealed that somatomedin-C doubled 
tyrosine  phosphorylation. 
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the  antibody, itself, stimulated  phosphorylation, or that so- 
matomedin-C could not  further increase phosphorylation  un- 
der  these  circumstances. 
DISCUSSION 
The interpretation of the results presented in this study 
depend in part  upon  the specificity of tuIR-2 and tuIR-3. This 
has been evaluated extensively  (27, 28). With  the  concentra- 
tions of antibody used in this  study,  both  nIR-2  and  nIR-3 
immunoprecipitate less than 2% of the amount of insulin 
receptor  immunoprecipitated by nIR-1  (27).  Furthermore, 
when IM-9 cells that were covalently affinity labeled with 
'"'I-insulin were solubilized, no detectable labeled receptor 
bands were immunoprecipitated by nIR-2 or nIR-3, while a 
very prominent labeled receptor band was immunoprecipi- 
tated by (VIR-1 (28). Therefore, in the present studies, the 
92,000-98,000 molecular weight phosphotyrosine  containing 
polypeptide immunoprecipitated by nIR-2  and tuIR-3 cannot 
be the  8-subunit of the  insulin receptor. 
In addition to its immunochemical specificity, there are 
other reasons for believing that this polypeptide is the @- 
subunit of the  somatomedin-C receptor. Its  phosphorylation 
is enhanced by ng/ml concentrations of somatomedin-C  and 
pg/ml concentrations of insulin, which is consistent with the 
known affinities of these  hormones for the  somatomedin-C 
receptor. Furthermore,  it  has a somewhat  broader  pattern  and 
a slightly slower mobility than  the  @-subunit of the insulin 
receptor, properties characteristic of the @-subunit of the 
somatomedin-C receptor in IM-9 cells. In some autoradi- 
ograms, this broad band appears to be a doublet. We had 
previously  suggested that  the lower component of this doublet 
might be the  @-subunit of the  insulin receptor (27).  This now 
seems unlikely,  because the  phosphorylation of both compo- 
nents of this  band  are  enhanced  to a similar  extent by various 
concentrations of insulin  and  somatomedin-C, whereas if the 
lower component was the  @-subunit of the  insulin receptor, 
one would expect a differential effect on  the  extent of phos- 
phorylation. 
Because of the  great  similarity between  receptors for insulin 
and  somatomedin-C, it may be anticipated by analogy with 
the insulin receptor that the somatomedin-C receptor is a 
protein kinase and that phosphorylation of its @-subunit 
results from endogenous protein kinase activity. The  reten- 
tion of protein  kinase  activity by a highly purified receptor 
preparation (i.e. after  wheat germ agglutinin-Sepharose  chro- 
matography  and  immunoprecipitation) is consistent with this; 
however, further  studies will be required to conclusively dem- 
onstrate  that  the receptor,  itself, is a protein kinase. 
The  present  studies  indicate  that when solubilized soma- 
tomedin-C receptor is phosphorylated, the phosphorylation 
occurs  on tyrosyl residues. This is true also for the solubilized 
insulin  receptor; however, when the  insulin receptor is phos- 
phorylated in intact cells, a considerable amount of phos- 
phoserine and phosphothreonine is present in addition to 
phosphotyrosine (15).  Further studies will be required to 
determine if in intact cells this more complex pattern of 
phosphorylation  also occurs  with somatomedin-C receptors. 
The  results  presented in Fig. 1 illustrate  that high concen- 
trations of insulin  stimulate  the  phosphorylation of the so- 
matomedin-C receptor, and high concentrations of somato- 
medin-C stimulate phosphorylation of the insulin receptor. 
As previously discussed, the most likely explanation for this 
is the known cross-reactivity of each  receptor for the  other's 
hormone; however, another possibility, which cannot be  ex- 
cluded, is that  each  receptor may be a substrate for the  other. 
Activation of one  receptor could then trigger the phosphoryl- 
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